TCL Archive NCI Plans Program To Help Academics With Initial Stages of Drug Discovery. November 30, 2007
TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005